International Journal of Gynecology & Obstetrics· 2019Q2
Revised FIGO staging for carcinoma of the cervix uteri
- 1,035citations
- Q2SCImago
- 2019year
Short summary
The FIGO staging for cervical cancer is revised to incorporate imaging and pathology findings, introducing new subgroups for Stage IB (IB1, IB2, IB3) based on tumor size and reclassifying lymph node involvement into Stage IIIC1 (pelvic only) and IIIC2 (para-aortic involvement).
AI-generated from the title and abstract; the full text is not read.
Key points
- Stage IA definition revised, removing lateral extension measurement.
- Stage IB now has three subgroups: IB1 (≥5 mm to <2 cm), IB2 (2-4 cm), and IB3 (≥4 cm).
- Lymph node metastasis is now Stage IIIC, with IIIC1 for pelvic nodes and IIIC2 for para-aortic nodes.
- New notations 'i' (imaging) and 'p' (pathology) will indicate the method used for staging.
AI-generated from the title and abstract; the full text is not read.
Abstract
OBJECTIVE: To revise FIGO staging of carcinoma of the cervix uteri, allowing incorporation of imaging and/or pathological findings, and clinical assessment of tumor size and disease extent. METHODS: Review of literature and consensus view of the FIGO Gynecologic Oncology Committee and related societies and organizations. RESULTS: In stage I, revision of the definition of microinvasion and lesion size as follows. Stage IA: lateral extension measurement is removed; stage IB has three subgroups-stage IB1: invasive carcinomas ≥5 mm and <2 cm in greatest diameter; stage IB2: tumors 2-4 cm; stage IB3: tumors ≥4 cm. Imaging or pathology findings may be used to assess retroperitoneal lymph nodes; if metastatic, the case is assigned stage IIIC; if only pelvic lymph nodes, the case is assigned stage IIIC1; if para-aortic nodes are involved, the case is assigned stage IIIC2. Notations 'r' and 'p' will indicate the method used to derive the stage-i.e., imaging or pathology, respectively-and should be recorded. Routine investigations and other methods (e.g., examination under anesthesia, cystoscopy, proctoscopy, etc.) are not mandatory and are to be recommended based on clinical findings and standard of care. CONCLUSION: The revised cervical cancer staging is applicable to all resource levels. Data collection and publication will inform future revisions.
The authors' abstract, as published at the source. International Journal of Gynecology & Obstetrics, 2019 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Obstetrics and Gynecology
Obstetrics and GynecologyMedicine